Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial Meeting Abstract
| Authors: | Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M.; Edenfield, W. J.; Wilding, G.; Martell, B.; Hariharan, S.; Figlin, R. A. |
| Abstract Title: | Randomized phase II multicenter study of the efficacy and safety of sunitinib on the 4/2 versus continuous dosing schedule as first-line therapy of metastatic renal cell carcinoma: Renal EFFECT Trial |
| Meeting Title: | 2011 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2011 Feb 17-19 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-03-01 |
| Language: | English |
| ACCESSION: | WOS:000208880700407 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2011.29.7_suppl.lba308 |
| Notes: | Meeting Abstract: LBA308 -- Source: Wos |
